Sensview, a developer of solid-state imaging chips and detector module products based in Chengdu, has reportedly secured tens of millions of renminbi in a Series A+ financing round. The round was led by Matrix Partners, with contributions from Suzhou Industrial Park Zhongyuan Naxing Venture Capital and Leli Capital, as well as existing investor HM Capital. The funds will be allocated towards the research and development of X-ray detectors and core chips, the expansion of manufacturing capacity, and market promotion efforts.
Sensview’s Business Footprint and Product Offerings
Founded in 2019, Sensview has established a business footprint that encompasses a range of high-performance X-ray imaging detectors, including CMOS flat panel detectors, CT detectors, photon counting detectors, and related signal chain ASIC chips. The company also specializes in other solid-state imaging chips and detectors based on monocrystalline silicon technology. These products are widely applied across the healthcare industry and other sectors, making Sensview a key player in the medical imaging technology space.
Expanding R&D and Market Reach
The proceeds from the Series A+ financing round will enable Sensview to further invest in the advancement of its X-ray detector and core chip technologies. This funding will also support the scaling up of manufacturing capabilities to meet growing demand and enhance market promotion activities, thereby strengthening Sensview’s position in the global medical imaging market.-Fineline Info & Tech
